نتایج جستجو برای: bruton

تعداد نتایج: 389  

2018
Carole Bitar Azeen Sadeghian Lacey Sullivan Andrea Murina

CLL: chronic lymphocytic leukemia PR: pityriasis rosea EGFR: epidermal growth factor receptor PDGFR: platelet-derived growth factor receptor I brutinib, a Bruton tyrosine kinase inhibitor, is a new oral agent approved for the treatment of chronic lymphocytic leukemia (CLL). Ibrutinib is well-tolerated, with the majority of its adverse events within grade 1 or 2 severity. The most common nonhema...

Journal: :Immunity 2010
Laura Belver Virginia G de Yébenes Almudena R Ramiro

MicroRNAs have been shown to be critical for a number of aspects of immune system regulation and function. Here, we have examined the role of microRNAs in terminal B cell differentiation by analyzing Cd19-Cre(ki/+) Dicer1(fl/fl) mice. We found that in the absence of Dicer, the transitional and marginal zone (MZ) B cell compartments were overrepresented and follicular (FO) B cell generation was ...

Journal: :Journal of the National Comprehensive Cancer Network : JNCCN 2012
Andrew D Zelenetz Leo I Gordon William G Wierda Jeremy S Abramson Ranjana H Advani C Babis Andreadis Nancy Bartlett John C Byrd Myron S Czuczman Luis E Fayad Richard I Fisher Martha J Glenn Nancy Lee Harris Richard T Hoppe Steven M Horwitz Christopher R Kelsey Youn H Kim Susan Krivacic Ann S LaCasce Auayporn Nademanee Pierluigi Porcu Oliver Press Rachel Rabinovitch Nishitha Reddy Erin Reid Ayman A Saad Lubomir Sokol Lode J Swinnen Christina Tsien Julie M Vose Joachim Yahalom Nadeem Zafar Mary Dwyer Hema Sundar

Non-Hodgkin's lymphomas (NHL) are a heterogeneous group of lymphoproliferative disorders originating in B lymphocytes, T lymphocytes, or natural killer cells. Mantle cell lymphoma (MCL) accounts for approximately 6% of all newly diagnosed NHL cases. Radiation therapy with or without systemic therapy is a reasonable approach for the few patients who present with early-stage disease. Rituximab-ba...

Journal: :Blood 2015
Sophie Bernard Lauriane Goldwirt Sandy Amorim Pauline Brice Josette Brière Eric de Kerviler Samia Mourah Hélène Sauvageon Catherine Thieblemont

The risk of central nervous system (CNS) dissemination in mantle cell lymphoma (MCL) is low and occurs late in the course of the disease. However, prognosis in such cases remains extremely poor despite high-dose antimetabolite chemotherapy. Among novel drugs used to treat relapsing MCL patients, ibrutinib, an oral inhibitor of Bruton tyrosine kinase, shows great promise. Here we report the clin...

Journal: :Blood 2004
Hidetoshi Takada Hirokazu Kanegane Akihiko Nomura Ken Yamamoto Kenji Ihara Yasuhiko Takahashi Satoshi Tsukada Toshio Miyawaki Toshiro Hara

We analyzed the cause of agammaglobulinemia in a girl whose father had been diagnosed as having X-linked agammaglobulinemia (XLA). Flow cytometric analysis revealed the lack of peripheral B cells with the block of B-cell differentiation in the stages between pro-B cells and pre-B cells in the bone marrow, and the defect of the Bruton tyrosine kinase (BTK) expression on monocytes. We found a BTK...

Journal: :Journal of leukocyte biology 1998
P Launay A Lehuen T Kawakami U Blank R C Monteiro

IgA Fc receptors (Fc alphaR) can mediate a variety of inflammatory responses. It has been demonstrated that the FcRgamma subunit is critical in mediating signaling through Fc alphaR. We show that aggregation of Fc alphaR on U937 cells and blood neutrophils results in tyrosine phosphorylation of several intracellular proteins, including the FcR gamma subunit, p72syk, and Bruton tyrosine kinase (...

2015
Nitin Jain Susan O’Brien

Chemoimmunotherapy (CIT) has been the standard first-line treatment of patients with chronic lymphocytic leukemia (CLL). In the last several years, major strides have been made in understanding the biology of CLL, and fortunately, several of these discoveries are making their way into the clinics. These include novel CD20 monoclonal antibodies (mAb) (ofatumumab and obinutuzumab), Bruton tyrosin...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید